204 related articles for article (PubMed ID: 25102319)
21. Respiratory Medications in Infants <29 Weeks during the First Year Postdischarge: The Prematurity and Respiratory Outcomes Program (PROP) Consortium.
Ryan RM; Keller RL; Poindexter BB; D'Angio CT; Shaw PA; Bellamy SL; Moore PE; McPherson C; Greenberg JM;
J Pediatr; 2019 May; 208():148-155.e3. PubMed ID: 30857774
[TBL] [Abstract][Full Text] [Related]
22. Pulmonary effect of inhaled furosemide in ventilated infants with severe bronchopulmonary dysplasia.
Prabhu VG
Pediatrics; 1997 Sep; 100(3 Pt 1):420-1. PubMed ID: 9304111
[No Abstract] [Full Text] [Related]
23. Early inhaled glucocorticoid therapy to prevent bronchopulmonary dysplasia.
Cole CH; Colton T; Shah BL; Abbasi S; MacKinnon BL; Demissie S; Frantz ID
N Engl J Med; 1999 Apr; 340(13):1005-10. PubMed ID: 10099142
[TBL] [Abstract][Full Text] [Related]
24. Sildenafil Treatment of Infants With Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension.
Backes CH; Reagan PB; Smith CV; Jadcherla SR; Slaughter JL
Hosp Pediatr; 2016 Jan; 6(1):27-33. PubMed ID: 26666265
[TBL] [Abstract][Full Text] [Related]
25. Pulmonary effect of inhaled furosemide in ventilated infants with severe bronchopulmonary dysplasia.
Kugelman A; Durand M; Garg M
Pediatrics; 1997 Jan; 99(1):71-5. PubMed ID: 8989341
[TBL] [Abstract][Full Text] [Related]
26. The effect of inhaled nitric oxide on pulmonary function in preterm infants.
Di Fiore JM; Hibbs AM; Zadell AE; Merrill JD; Eichenwald EC; Puri AR; Mayock DE; Courtney SE; Ballard RA; Martin RJ
J Perinatol; 2007 Dec; 27(12):766-71. PubMed ID: 17805339
[TBL] [Abstract][Full Text] [Related]
27. [Bronchopulmonary dysplasia and corticosteroid therapy].
Chérif A; Marrakchi Z; Chaouachi S; Boukef S; Sfar R
Arch Pediatr; 2002 Feb; 9(2):159-68. PubMed ID: 11915499
[TBL] [Abstract][Full Text] [Related]
28. Rationale for spacer use in children.
Dolovich M
Pediatr Pulmonol Suppl; 1997; 16():184-5. PubMed ID: 9443266
[No Abstract] [Full Text] [Related]
29. WITHDRAWN. Inhaled steroids for neonatal chronic lung disease.
Lister P; Iles R; Shaw BNj; Ducharme FM
Cochrane Database Syst Rev; 2010 Jan; (1):CD002311. PubMed ID: 20091533
[TBL] [Abstract][Full Text] [Related]
30. Inhaled steroids for neonatal chronic lung disease.
Lister P; Iles R; Shaw B; Ducharme F
Cochrane Database Syst Rev; 2000; (3):CD002311. PubMed ID: 10908553
[TBL] [Abstract][Full Text] [Related]
31. Economic evaluation of inhaled nitric oxide in preterm infants undergoing mechanical ventilation.
Zupancic JA; Hibbs AM; Palermo L; Truog WE; Cnaan A; Black DM; Ballard PL; Wadlinger SR; Ballard RA;
Pediatrics; 2009 Nov; 124(5):1325-32. PubMed ID: 19841125
[TBL] [Abstract][Full Text] [Related]
32. [Bronchopulmonary dysplasia-associated pulmonary arterial hypertension of very preterm infants].
Meau-Petit V; Thouvenin G; Guillemot-Lambert N; Champion V; Tillous-Borde I; Flamein F; de Saint Blanquat L; Essouri S; Guilbert J; Nathan N; Guellec I; Kout S; Epaud R; Lévy M
Arch Pediatr; 2013 Jan; 20(1):44-53. PubMed ID: 23266170
[TBL] [Abstract][Full Text] [Related]
33. Home Oxygen Use and 1-Year Readmission among Infants Born Preterm with Bronchopulmonary Dysplasia Discharged from Children's Hospital Neonatal Intensive Care Units.
Lagatta J; Murthy K; Zaniletti I; Bourque S; Engle W; Rose R; Ambalavanan N; Brousseau D
J Pediatr; 2020 May; 220():40-48.e5. PubMed ID: 32093927
[TBL] [Abstract][Full Text] [Related]
34. Postnatal nutritional deficit is an independent predictor of bronchopulmonary dysplasia among extremely premature infants born at or less than 28 weeks gestation.
Malikiwi AI; Lee YM; Davies-Tuck M; Wong FY
Early Hum Dev; 2019 Apr; 131():29-35. PubMed ID: 30825742
[TBL] [Abstract][Full Text] [Related]
35. Assessment of bronchodilator response by forced oscillation technique in a preterm infant with evolving bronchopulmonary dysplasia: A case report.
Rigotti C; Zannin E; Abdelfattah AS; Ventura ML; Dellacà RL
Pediatr Pulmonol; 2022 Apr; 57(4):1092-1095. PubMed ID: 34970872
[TBL] [Abstract][Full Text] [Related]
36. Bronchopulmonary dysplasia in very low birth weight infants.
Demirel N; Bas AY; Zenciroglu A
Indian J Pediatr; 2009 Jul; 76(7):695-8. PubMed ID: 19381510
[TBL] [Abstract][Full Text] [Related]
37. Inhaled Drugs and Systemic Corticosteroids for Bronchopulmonary Dysplasia.
Bassler D; van den Anker J
Pediatr Clin North Am; 2017 Dec; 64(6):1355-1367. PubMed ID: 29173790
[TBL] [Abstract][Full Text] [Related]
38. Effects of Multiple Ventilation Courses and Duration of Mechanical Ventilation on Respiratory Outcomes in Extremely Low-Birth-Weight Infants.
Jensen EA; DeMauro SB; Kornhauser M; Aghai ZH; Greenspan JS; Dysart KC
JAMA Pediatr; 2015 Nov; 169(11):1011-7. PubMed ID: 26414549
[TBL] [Abstract][Full Text] [Related]
39. [Application of inhaled nitric oxide in extreme preterm neonates with with BPD].
Radulova P; Slancheva B
Akush Ginekol (Sofiia); 2014; 53(4):46-50. PubMed ID: 25510071
[TBL] [Abstract][Full Text] [Related]
40. Enteral iron supplementation, red blood cell transfusion, and risk of bronchopulmonary dysplasia in very-low-birth-weight infants.
Patel RM; Knezevic A; Yang J; Shenvi N; Hinkes M; Roback JD; Easley KA; Josephson CD
Transfusion; 2019 May; 59(5):1675-1682. PubMed ID: 30801736
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
